Laws · international

Greece Bans Cannabis Flower Products in Nationwide Retail Crackdown

Greek authorities ordered immediate removal of all cannabis flower products from retail shelves, ending three years of legal ambiguity.

By Tomas Greer, State Policy ReporterPublished May 24, 20264 min read
View of the Pallas Athene Fountain and Parliament Building in Vienna, Austria.

View of the Pallas Athene Fountain and Parliament Building in Vienna, Austria.

Greece banned the retail sale of cannabis flower products on May 23, 2026, ordering stores nationwide to remove all flower-based items from shelves immediately. The crackdown closes a regulatory loophole that allowed hemp flower sales since 2023 under EU industrial hemp rules, affecting an estimated 2,000 retail outlets across the country.

Immediate Enforcement Targets Hemp Flower Retailers

Greek regulatory authorities issued the ban without advance notice, directing law enforcement to conduct compliance sweeps beginning May 24. The order applies to all cannabis flower products regardless of THC content, including hemp flower sold under the EU's 0.3% THC threshold. Retailers have 72 hours to clear inventory. After that, administrative fines start at €10,000 per violation.

The Greek National Organization for Medicines (EOF) issued the directive under existing pharmaceutical regulations that classify all cannabis flower as a controlled substance requiring medical dispensing licenses. No retailers outside the country's limited medical cannabis program hold such licenses.

Legal Ambiguity Collapses After Three-Year Tolerance Period

Since 2023, Greek retailers operated under an informal understanding that EU industrial hemp regulations permitted flower sales if THC levels stayed below 0.3%. That interpretation relied on EU Regulation 1307/2013, which governs hemp cultivation for fiber and seed but doesn't explicitly authorize flower retail. Greek authorities never formally endorsed the practice. They didn't enforce prohibitions until this week.

The ban follows mounting pressure from Greece's medical cannabis licensees, who argued that unregulated flower sales undercut their tightly controlled market. Greece authorized medical cannabis cultivation and distribution in 2017 under Law 4523/2018, but fewer than 15 licensed pharmacies currently dispense products.

Estimated €120 Million Market Faces Overnight Shutdown

Industry observers estimate Greece's hemp flower retail sector generated €100–120 million in annual sales across approximately 2,000 specialty shops, convenience stores, and kiosks. The market expanded rapidly in 2024 and 2025 as operators imported bulk flower from Italy, Spain, and Switzerland, then repackaged it for domestic sale.

No compensation or transition period has been announced. Retailers holding inventory face total write-offs unless they can return unsold stock to foreign suppliers within days. The ban doesn't affect non-flower hemp products such as oils, edibles, or cosmetics, provided they contain no detectable THC.

Enforcement Mechanism Relies on Pharmaceutical Classification

The EOF justified the ban by citing Article 12 of Law 4523/2018, which designates all cannabis flower as a pharmaceutical product subject to prescription-only distribution. That statute predates the 2023 retail boom but wasn't enforced against hemp flower until now. The EOF's interpretation aligns Greece with stricter EU member states like France and Sweden, which prohibit flower sales even when THC content is negligible.

Greek police and municipal health inspectors will conduct spot checks through June 2026. Repeat violations carry criminal penalties. Those include six-month license suspensions and potential prosecution under drug-distribution statutes.

Medical Cannabis Program Remains Unchanged

Greece's medical cannabis framework, operational since 2019, continues without modification. Patients with qualifying conditions can obtain cannabis products through licensed pharmacies after securing physician approval. Eligible conditions include chronic pain, multiple sclerosis, and chemotherapy side effects. Fewer than 5,000 patients are currently enrolled, according to 2025 EOF data.

The medical program allows only cannabis oils, capsules, and tinctures. Smokable flower isn't available even to registered patients. Cultivation licenses remain limited to four domestic producers and a handful of import permits for finished goods.

Regional Precedent and EU Regulatory Tension

Greece's move mirrors recent crackdowns in France and Austria, where authorities closed hemp flower retailers in 2024 and 2025 despite EU cultivation rules. The European Court of Justice hasn't issued a binding ruling on whether EU hemp regulations preempt national bans on flower retail. Until a definitive ECJ decision, member states retain discretion to prohibit flower sales under public-health or pharmaceutical-control statutes.

For full background on this regulatory shift, see the CannIntel topic hub on Greece Cannabis Regulation. Industry groups in Italy and Spain—major exporters to Greece—haven't yet commented on the ban's impact on cross-border hemp trade.

What Comes Next for Greek Retailers

The EOF hasn't announced plans to revisit the ban or create a licensed flower-retail category. Retailers are exploring legal challenges under EU trade law, but no formal complaints have been filed. The next signal to watch: whether Greece's enforcement triggers a broader EU debate on harmonizing hemp flower policy, or whether member-state discretion remains the norm. We'll be monitoring EOF guidance and any court filings through June 2026.

Full context

For complete background, history, and our ongoing coverage of this story:

Open the CannIntel topic hub →

Frequently asked questions

Why did Greece ban cannabis flower products?

Greek authorities enforced existing pharmaceutical law (Law 4523/2018) that classifies all cannabis flower as prescription-only, closing a three-year tolerance period for hemp flower retail under EU industrial hemp rules.

Does the ban affect CBD oils or edibles?

No. The ban targets only cannabis flower products. Non-flower hemp items like oils, edibles, and cosmetics remain legal if they contain no detectable THC.

Can Greek medical cannabis patients still access flower?

No. Greece's medical program has never permitted smokable flower. Patients access only oils, capsules, and tinctures through licensed pharmacies.

What penalties do retailers face for non-compliance?

Initial fines start at €10,000 per violation. Repeat offenses carry six-month license suspensions and potential criminal prosecution under drug-distribution statutes.

Will EU law override Greece's ban?

Not yet. The European Court of Justice has not issued a binding ruling on whether EU hemp cultivation rules preempt national flower-retail bans. Member states retain discretion under public-health authority.

Sources

Greecehemp flower banLaw 4523/2018EOFEU hemp regulationmedical cannabis Greece
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom